Loading company…
Chicago-based medical technology company making the Novilase Interstitial Laser System for minimally invasive breast tumor treatment.
Novian Health Inc. is headquartered in Chicago, US, and Chip Appelbaum is CEO. Its Novilase system uses ultrasound guidance to treat malignant and benign breast tumors, and has CE Mark and FDA Breakthrough Device designation. In July 2021 the company raised USD 1.00 mn in venture debt for general working capital. It is listed at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in